Actual Medicinal Product (AMP) Besavar XL 10mg tablets (Zentiva Pharma UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability: There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
Notes: Slightly hygroscopic. Protect from light. Max 7 days in MCA.
Provenance: This compatibility recommendation is derived from Besavar XL 10mg tablets (Zentiva Pharma UK Ltd), Xatral XL 10mg tablets (Sanofi) and Vasran XL 10mg tablets (Ranbaxy (UK) Ltd).
Generic: Alfuzosin
Formulation: Alfuzosin 10mg modified-release tablets